Collegium Pharmaceutical issues 2026 financial guidance
Go back to Collegium Pharmaceutical issues 2026 financial guidance| (NASDAQ: COLL) | Delayed: 23.77 +0.85 (3.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.92 | 52 Week High | $30.58 | |||
| Open | $23.03 | 52 Week Low | $8.24 | |||
| Day High | $23.77 | P/E | N/A | |||
| Day Low | $22.94 | EPS | $0.00 | |||
| Volume | 256,137 | |||||



